# S-Metoprolol XR 25-50 mg Tablets vs Metoprolol Zok 50-100 mg Tablets in Hypertension Patients.

Study · id `cardio:ct-nct04457323` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT04457323](<https://clinicaltrials.gov/study/NCT04457323>), retrieved 26 October 2026. No person wrote or checked this page.

Also called: NCT04457323

Browse, organ or system: Blood vessels  
Browse, condition area: High blood pressure  

## In plain language

A phase 4 trial registered on ClinicalTrials.gov. The registry status is unknown. It plans to enroll 126 participants.

## Technical summary

Registry record NCT04457323. Randomized; double masking; primary purpose treatment. Start 2022-01-15 (anticipated); primary completion 2022-10-15 (anticipated). Results not posted.

## Key facts

- Design: Interventional study; randomized; double masking; primary purpose treatment
- Phase: Phase 4
- Enrolled: 126 participants (planned count; ClinicalTrials.gov record NCT04457323, source copy `cardio:ctgov-nct04457323-2021-12-10`, retrieved 2026-10-26)
- Planned start: 2022-01-15 (anticipated) (ClinicalTrials.gov record NCT04457323, source copy `cardio:ctgov-nct04457323-2021-12-10`, retrieved 2026-10-26)
- Primary completion: 2022-10-15 (anticipated) (ClinicalTrials.gov record NCT04457323, source copy `cardio:ctgov-nct04457323-2021-12-10`, retrieved 2026-10-26)
- Completion: 2022-12-15 (anticipated) (ClinicalTrials.gov record NCT04457323, source copy `cardio:ctgov-nct04457323-2021-12-10`, retrieved 2026-10-26)
- Countries: Not reported
- Care setting: Not reported
- Registry status: "UNKNOWN" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct04457323-2021-12-10`, retrieved 2026-10-26)

## The registry's words

- Brief title: S-Metoprolol XR 25-50 mg Tablets vs Metoprolol Zok 50-100 mg Tablets in Hypertension Patients.
- Condition: Hypertension
- Intervention (Drug): Metoprolol
- Intervention (Drug): Metoprolol
- Lead sponsor: Neutec Ar-Ge San ve Tic A.Ş
- Lead sponsor class: INDUSTRY

## Connected pages

- Registry condition terms include this condition: Hypertension (high blood pressure) (`core:hypertension`)
- Registry intervention name matches this record: Metoprolol (`cardio:metoprolol`)
- Registry intervention is a member of this class by a sourced record link: Beta-blockers (drug class) (`cardio:beta-blockers`)

## Provenance

Content hash: 1018927ef520678b726231bd41f1f5a40d72a8c2bf657969db524f7f5d40547b
Last substantive edit: 2026-11-18
Evidence last checked: Not recorded
